Category News

Pfizer Reports Encouraging Overall Survival Results in Phase 3 Study of ADCETRIS® Treatment for Relapsed/Refractory Diffuse Large B-cell Lymphoma

Pfizer Inc. (NYSE: PFE) has disclosed promising findings from a Phase 3 clinical trial investigating the efficacy of the antibody-drug conjugate ADCETRIS® (brentuximab vedotin) in conjunction with lenalidomide and rituximab for treating patients afflicted with relapsed/refractory diffuse large B-cell lymphoma…

Read MorePfizer Reports Encouraging Overall Survival Results in Phase 3 Study of ADCETRIS® Treatment for Relapsed/Refractory Diffuse Large B-cell Lymphoma

Update Consultation by WHO Experts: Revising Toxic Equivalency Factors for Dioxin-like Compounds and Selected Polychlorinated Biphenyls

In Lisbon, Portugal, the World Health Organization (WHO) recently hosted an expert panel to reassess the Toxic Equivalency Factors (TEFs) for chlorinated dioxin-like compounds, initially established in 2005. Background: Since the 1990s, WHO has consistently organized expert consultations aimed at…

Read MoreUpdate Consultation by WHO Experts: Revising Toxic Equivalency Factors for Dioxin-like Compounds and Selected Polychlorinated Biphenyls

Neurological Conditions Impact Over 1 in 3 Individuals, Ranking as the Primary Cause of Global Illness and Disability

A recent comprehensive study, published in The Lancet Neurology, has revealed staggering figures regarding neurological conditions worldwide. In 2021, over 3 billion individuals were found to be living with such conditions, marking them as the foremost cause of global illness…

Read MoreNeurological Conditions Impact Over 1 in 3 Individuals, Ranking as the Primary Cause of Global Illness and Disability

WHO and UNICEF Introduce Complimentary Online Course on Children’s Environmental Health

Amidst the escalating challenges posed by environmental pollution and climate change, the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF) have joined forces to launch a new online course, free of charge, aimed at empowering healthcare providers…

Read MoreWHO and UNICEF Introduce Complimentary Online Course on Children’s Environmental Health

Gender Disparities Unveiled: The Core of the Worldwide Health and Care Work Crisis, According to WHO Report

The latest publication from the World Health Organization (WHO), titled “Equity in Health and Care: Gender Dynamics in Undervalued Health and Care Labor,” sheds light on how gender disparities within health and care sectors detrimentally affect women, health infrastructures, and…

Read MoreGender Disparities Unveiled: The Core of the Worldwide Health and Care Work Crisis, According to WHO Report

Alnylam’s KARDIA-2 Study Shows Zilebesiran Adds Significant Blood Pressure Reduction

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a pioneer in RNAi therapeutics, has announced positive results from the KARDIA-2 Phase 2 study of zilebesiran, an investigational RNAi therapeutic targeting liver-expressed angiotensinogen (AGT) for treating hypertension. The study met its primary endpoint, demonstrating…

Read MoreAlnylam’s KARDIA-2 Study Shows Zilebesiran Adds Significant Blood Pressure Reduction

Argonaut Manufacturing Services Boosts Aseptic Pharma Filling with $45M Investment

Argonaut Manufacturing Services Secures $45M Funding for Expanded Pharma Fill / Finish Facility Argonaut Manufacturing Services, a prominent contract development and manufacturing organization in the biopharma and life sciences sectors, has finalized a $45 million financing deal to bolster its…

Read MoreArgonaut Manufacturing Services Boosts Aseptic Pharma Filling with $45M Investment